Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
manufactured for Rising Pharmaceuticals, Allendale, New JerseyScope: 1,200 bottles of 5-capsule, 5 mg strengthDrug Purpose: Oral chemotherapy used to treat glioblastoma and other brain tumorsRecall Reason: An out-of-specification result was observed during long-term stability testing at 9 months
Food and Drug Administration (FDA) for the treatment, cure, mitigation, or prevention of any disease
We found a significant decrease in erythrocytes in relation to an ICU stay
Reduce basal insulin by 20% Reduce mealtime bolus insulin by 20 to 30% Do not reduce correction insulin initially (use for glucose above 180 mg/dL as usual) Step 3: Monitoring phase (weeks 1 to 4)
US$ 22.39
US$ 26.88
US$ 26.06
US$ 22.86
US$ 26.99
US$ 20.70
